Science & Technology International is committed to developing, refining, and applying highly advanced optical imaging technology to advance the detection, diagnosis, and treatment of cancer.

Science & Technology International’s parent company, STI Industries, is a global leader in developing optical imaging systems for a wide array of applications including medical, environmental, and national defense. When STI Industries transitioned its classified military technologies to the medical device arena, Science & Technology International was founded.

A proven management team with core competencies in technology and product development, regulatory, clinical and product marketing are cornerstones of our medical business.

Harnessing capabilities in optics, image processing, and systems engineering and integration has allowed Science & Technology International to develop a compelling and proprietary product line to address unmet medical needs.

The company is interested in cultivating other applications for its technologies through various means, including strategic partnerships and acquisitions. Science & Technology International is making a continual investment in its ImageSense technology platform and is researching stereoscopic applications, portable applications, as well as other additional highly advanced applications of this innovative, proprietary technology.

Based in Honolulu, Hawaii, Science & Technology International is poised to revolutionize early cancer detection and establish new standards of care.